Search research articles
Contact Us
Filters
Showing results (411-420 of 579) with videos related to
Page
of 58
Sort By:
Archives of General Psychiatry
|
February 9, 2011
The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels
Brit-Maren M Schjeide, Cathrin Schnack, Jean-Charles Lambert, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 19, 2016
Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme
Kevin D Rynearson, Ronald N Buckle, Keith D Barnes, et al.
Human Molecular Genetics
|
May 23, 2013
Silencing of the Drosophila ortholog of SOX5 in heart leads to cardiac dysfunction as detected by optical coherence tomography
Airong Li, Osman O Ahsen, Jonathan J Liu, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Discovery of Abundant Nano-scale Lymphatic-like Vessels in Brains
Shiju Gu, Hongquan Dong, Hao Chen, et al.
European Journal of Medicinal Chemistry
|
April 25, 2023
Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors
Gang Liu, Prasenjit Mondal, Na Sang, et al.
Frontiers in Pharmacology
|
August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease
Ben Boyarko, Sonia Podvin, Barry Greenberg, et al.
Genetic Epidemiology
|
June 9, 2025
Uncovering Ethnicity-Specific Recessive Loci for Alzheimer's Disease in 89 Dominican Families Using Family-Based WGS Analysis
Sanghun Lee, Julian Hecker, Badri N Vardarajan, et al.
Journal of Alzheimer'S Disease : JAD
|
February 13, 2021
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease
Timothy M Shoup, Ana Griciuc, Marc D Normandin, et al.
European Neurology
|
March 31, 1998
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity
C Hock, S Golombowski, F Müller-Spahn, et al.
Eclinicalmedicine
|
December 8, 2025
Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial
Chao-Yi Wu, William Cody Reynolds, Isabel Abril, et al.
Page
of 58
Search research articles
Search
Showing results (411-420 of 579) with videos related to
Sort By:
Page
of 58
Archives of General Psychiatry
|
February 9, 2011
The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels
Brit-Maren M Schjeide, Cathrin Schnack, Jean-Charles Lambert, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 19, 2016
Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme
Kevin D Rynearson, Ronald N Buckle, Keith D Barnes, et al.
Human Molecular Genetics
|
May 23, 2013
Silencing of the Drosophila ortholog of SOX5 in heart leads to cardiac dysfunction as detected by optical coherence tomography
Airong Li, Osman O Ahsen, Jonathan J Liu, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Discovery of Abundant Nano-scale Lymphatic-like Vessels in Brains
Shiju Gu, Hongquan Dong, Hao Chen, et al.
European Journal of Medicinal Chemistry
|
April 25, 2023
Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors
Gang Liu, Prasenjit Mondal, Na Sang, et al.
Frontiers in Pharmacology
|
August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease
Ben Boyarko, Sonia Podvin, Barry Greenberg, et al.
Genetic Epidemiology
|
June 9, 2025
Uncovering Ethnicity-Specific Recessive Loci for Alzheimer's Disease in 89 Dominican Families Using Family-Based WGS Analysis
Sanghun Lee, Julian Hecker, Badri N Vardarajan, et al.
Journal of Alzheimer'S Disease : JAD
|
February 13, 2021
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease
Timothy M Shoup, Ana Griciuc, Marc D Normandin, et al.
European Neurology
|
March 31, 1998
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity
C Hock, S Golombowski, F Müller-Spahn, et al.
Eclinicalmedicine
|
December 8, 2025
Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial
Chao-Yi Wu, William Cody Reynolds, Isabel Abril, et al.
Page
of 58